Filter
927
Filtered Results: 927
Text search:
The
Lancet
Respiratory
Medicine
Featured
Recommendations
107
New Publications
141
Language
Document type
No document type
352
Studies & Reports
261
Guidelines
199
Manuals
36
Fact sheets
27
Strategic & Response Plan
25
Training Material
14
Situation Updates
8
Resource Platforms
3
Infographics
2
Countries / Regions
Global
52
India
34
Brazil
26
South Africa
24
Africa
22
Germany
20
Western and Central Europe
20
Latin America and the Carribbean
18
Russia
17
Kenya
15
Ethiopia
13
Nigeria
12
Colombia
12
Paraguay
10
West and Central Africa
9
Eastern Europe and Central Asia
9
Spain
9
Liberia
8
Nepal
8
Bangladesh
8
South–East Asia Region
8
Uganda
7
Philippines
7
Ukraine
7
Eastern Europe
7
Syria
6
Malawi
6
Mozambique
6
Argentina
6
Myanmar / Burma
6
Chile
6
East and Southern Africa
6
Sierra Leone
5
Rwanda
5
Peru
5
Ecuador
5
Guinea
4
USA
4
Zambia
4
Tanzania
4
Venezuela
4
Burkina Faso
3
Senegal
3
Congo, Democratic Republic of
3
Ghana
3
Pakistan
3
Thailand
3
China
3
Namibia
3
Yemen
3
Middle East and North Africa
3
Western Pacific Region
3
Italy
3
North America
3
France
3
Cameroon
2
Haiti
2
Jordan
2
Afghanistan
2
Turkey
2
Papua New Guinea
2
Sudan
2
Eswatini/ Swaziland
2
Botswana
2
Bolivia
2
Angola
2
Lesotho
2
Mexico
2
Asia
2
Kyrgyzstan
2
Kazakhstan
2
Vietnam
2
Portugal
2
Mali
1
Guinea-Bissau
1
Somalia
1
South Sudan
1
Iraq
1
Lebanon
1
Egypt
1
Cambodia
1
Indonesia
1
El Salvador
1
Greece
1
Sri Lanka
1
Albania
1
Laos
1
Canada
1
Tajikistan
1
Uruguay
1
Denmark
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
98
Public Health
70
Women & Child Health
51
Key Resources
23
Capacity Building
9
Pharmacy & Technologies
8
Toolboxes
COVID-19
221
TB
98
Planetary Health
61
NCDs
56
AMR
49
HIV
40
Mental Health
36
Ebola
27
Rapid Response
27
Caregiver
26
Global Health Education
19
Pharmacy
18
NTDs
14
Refugee
11
Conflict
8
Disability
6
Polio
6
Natural Hazards
4
Health Financing Toolbox
4
Zika
3
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized contro...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and t...
Guidelines on sanitation and health
recommended
The new WHO Guidelines on Sanitation and Health summarize the evidence on the effectiveness of a range of sanitation interventions and provide a co...
The core of the strategy is the goal for all patients to have better overall care, so that the ...
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; ...
The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary heal...
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for ... treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical trials testing the efficacy and safety of several medicines for COVID-19, as of the date of this document, there is a lack of quality evidence to demonstrate chloroquine and/or hydroxychloroquine are effective in the treatment of COVID-19. Evidence is recently emerging via small studies with sub-optimal methodologies that are conflicting.
Anaesthesia Tutorial of the Week
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate ...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the cl...
The prevalence of chronic non-communicable diseases such as diabetes, cardiovascular diseases and cancers has been on the increase in Kenya in ... recent past. This has been occasioned by changes in social and demographic situation in the country. The life expectancy in the country is improving, while the country is developing at a rapid pace. This has resulted in people living more years and at the time adopting lifestyles that have negative impacts on their health. This increase in diabetes and other non-communicable diseases has given rise to a double burden of communicable and non-communicable diseases in Kenya
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as ... most common chronic disease in children, issues of underdiagnosis and undertreatment persist. There are substantial global variations in the prevalence of asthma symptoms in children, with up to 13-fold differences between countries. The rising number of hospital admissions for asthma may reflect an increase in asthma severity, poor disease management and/or the effect of poverty. The financial burden of asthma is relatively high within developed countries (those for which data is available) spending 1 to 2% of their healthcare budget on this condition. Established in 1989, the Global Initiative for Asthma (GINA) attempts to raise awareness about the increasing prevalence of asthma, improve management and reduce the burden of asthma worldwide. Despite global efforts, GINA has not achieved its goal, even among developed nations. There are multiple barriers to reducing the global burden of asthma, including limited access to care and/or medications, and lack of prioritization as a public healthcare priority. In addition, the diversity of healthcare systems worldwide and large differences in access to care require that asthma management guidelines be tailored to local needs.
Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020
As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discu...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems a...
Public Health is the science field dedicated to promoting health and well-being, and preventing disease within the human population to ultimately increase ... quality of our livelihood and life span. Public Health does not focus on individual patients or diseases, but rather a given population and health system. The discipline is community-centered in its interventions and seeks to improve the health status of whole populations...
This paper summarizes the evidence about the health effects of air pollution from particulate matter and their implications for policy-makers, with the...
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
